This invention provides an improved process for preparing cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-2-methoxy-5,6,7,8-te- trahydronaphthalene hydrochloride which is an intermediate for the preparation of (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahyd- ronaphthalene-2-ol which is useful for the treatment of osteoporosis.

 
Web www.patentalert.com

< HUMAN SKELETAL MUSCLE-SPECIFIC UBIQUITIN-CONJUGATING ENZYME

< AZEPINO[4,5-B]INDOLES AND METHODS OF USE

> Compositions and Methods for Increasing Bone Mineralization

> METHOD AND APPARATUS FOR MAGNETIC INDUCTION THERAPY

~ 00618